ENDPQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ENDPQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Endo International's change in receivables for the quarter that ended in Dec. 2023 was $5 Mil. It means Endo International's Accounts Receivable declined by $5 Mil from Sep. 2023 to Dec. 2023 .
Endo International's change in receivables for the fiscal year that ended in Dec. 2023 was $107 Mil. It means Endo International's Accounts Receivable declined by $107 Mil from Dec. 2022 to Dec. 2023 .
Endo International's Accounts Receivable for the quarter that ended in Dec. 2023 was $387 Mil.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Endo International's Days Sales Outstanding for the three months ended in Dec. 2023 was 70.93.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Endo International's liquidation value for the three months ended in Dec. 2023 was $-10,544 Mil.
The historical data trend for Endo International's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Endo International Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Change In Receivables | Get a 7-Day Free Trial | 19.16 | -45.79 | -82.05 | 105.91 | 106.51 |
Endo International Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Change In Receivables | Get a 7-Day Free Trial | -48.73 | 37.69 | 6.23 | 57.57 | 5.02 |
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $107 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Endo International (OTCPK:ENDPQ) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Endo International's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 386.919 | / | 497.734 | * | 91 |
= | 70.93 |
2. In Ben Graham's calculation of liquidation value, Endo International's accounts receivable are only considered to be worth 75% of book value:
Endo International's liquidation value for the quarter that ended in Dec. 2023 is calculated as:
Liquidation Value | |||||||
= | Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | + | (0.75 * Accounts Receivable) | + | (0.5 * Total Inventories) |
= | 777.919 | - | 11734.854 | + | 0.75 * 386.919 | + | 0.5 * 246.017 |
= | -10,544 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Endo International's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
James Patrick Tursi | officer: Executive VP, Global R&D | 106 ASHLEY COURT, MOORESTOWN NJ 08057 |
Frank B. Raciti | officer: VP, Controller and CAO | C/O ENDO HEALTH SOLUTIONS INC., 1400 ATWATER DRIVE, MALVERN PA 19355 |
Shane Cooke | director | TREASURY BUILDING LOWER GRAND CANAL ST., DUBLIN 2 L2 00000 |
William P Montague | director | |
Jennifer M Chao | director | 7 PURITAN WOODS ROAD, RYE NY 10580 |
George Apostol | officer: EVP, Head of Global R&D | C/O ENDO INTERNATIONAL PLC, FIRST FL, MINERVA HOUSE, SIMMONSCOURT RD, BALLSBRIDGE, DUBLIN 4 L2 00000 |
Mary Christine Smith | director | 3658 50TH AVE NE, SEATTLE WA 98105 |
Mark T. Bradley | officer: EVP, Chief Financial Officer | C/O ENDO INTERNATIONAL PLC, FIRST FL, MINERVA HOUSE, SIMMONSCOURT RD, BALLSBRIDGE, DUBLIN L2 00000 |
Mark G Barberio | director | 19 WIK STREET, WILLIAMSVILLE NY 14221 |
Jack D. Boyle | officer: SVP, Interim Controller | C/O ENDO INTERNATIONAL PLC, FIRST FL, MINERVA HOUSE, SIMMONSCOURT RD, BALLSBRIDGE, DUBLIN L2 00000 |
Roger H Kimmel | director | LATHAM & WATKINS, 885 THIRD AVENUE, NEW YORK NY 10022 |
Domenico Ciarico | officer: EVP & Chief Commercial Officer | C/O ENDO INTERNATIONAL PLC, FIRST FL, MINERVA HOUSE, SIMMONSCOURT RD, BALLSBRIDGE, DUBLIN L2 00000 |
Rahul Garella | officer: EVP, Intl Pharmaceuticals | C/O ENDO INTERNATIONAL PLC, FIRST FL, MINERVA HOUSE, SIMMONSCOURT RD, BALLSBRIDGE, DUBLIN L2 00000 |
Nancy J Hutson | director | 64 MONTAUK AVENUE, STONINGTON CT 06378 |
Carrie Ann Nichol | officer: VP, Controller & CAO | 927 GRANDVIEW DRIVE, EXTON PA 19341 |
From GuruFocus
By PRNewswire PRNewswire • 08-09-2022
By PRNewswire • 06-29-2023
By PRNewswire • 08-08-2023
By PRNewswire PRNewswire • 04-26-2023
By PRNewswire • 06-26-2023
By PRNewswire PRNewswire • 07-11-2022
By PRNewswire PRNewswire • 07-11-2022
By PRNewswire PRNewswire • 07-13-2022
By PRNewswire PRNewswire • 12-06-2022
By PRNewswire • 09-21-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.